239785 Sigma-AldrichCyclophosphamide Monohydrate - CAS 6055-19-2 - Calbiochem
A widely used anti-neoplastic agent that also displays immunosuppressant properties.
More>> A widely used anti-neoplastic agent that also displays immunosuppressant properties. Less<<Cyclophosphamide Monohydrate - CAS 6055-19-2 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
同义词: N,N-bis(2-Chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine-2-oxide Monohydrate, CPA
Recommended Products
概述
| Replacement Information |
|---|
重要规格表
| CAS # | Empirical Formula |
|---|---|
| 6055-19-2 | C₇H₁₅Cl₂N₂O₂P · H₂O |
Products
| 产品目录编号 | 包装 | 数量 / 包装 | |
|---|---|---|---|
| 239785-1GMCN | 玻璃瓶 | 1 gm |
| References | |
|---|---|
| References | Wang, G.J., and Cai, L. 1999. Mutat. Res. 427, 125. Lee, J.H., et al. 1997. Korean J. Med. Sci. 12, 185. |
| Product Information | |
|---|---|
| CAS number | 6055-19-2 |
| ATP Competitive | N |
| Form | White solid |
| Hill Formula | C₇H₁₅Cl₂N₂O₂P · H₂O |
| Chemical formula | C₇H₁₅Cl₂N₂O₂P · H₂O |
| Reversible | N |
| Structure formula Image | |
| Quality Segment | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | Fas/Fas ligand pathway |
| Purity | ≥98% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS | |
|---|---|
| RTECS | RP6157750 |
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade ITEM Number | |
|---|---|
| 产品目录编号 | GTIN |
| 239785-1GMCN | 04055977199567 |
Documentation
Cyclophosphamide Monohydrate - CAS 6055-19-2 - Calbiochem MSDS
| 职位 |
|---|
Cyclophosphamide Monohydrate - CAS 6055-19-2 - Calbiochem 分析证书
| 标题 | 批号 |
|---|---|
| 239785 |
参考
| 参考信息概述 |
|---|
| Wang, G.J., and Cai, L. 1999. Mutat. Res. 427, 125. Lee, J.H., et al. 1997. Korean J. Med. Sci. 12, 185. |



